These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6086774)

  • 1. Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus.
    Barrett AD; Dimmock NJ
    J Infect Dis; 1984 Jul; 150(1):98-104. PubMed ID: 6086774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.
    Barrett AD; Guest AR; Mackenzie A; Dimmock NJ
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice.
    Crouch CF; Mackenzie A; Dimmock NJ
    J Infect Dis; 1982 Sep; 146(3):411-6. PubMed ID: 6286798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles.
    Atkinson T; Barrett AD; Mackenzie A; Dimmock NJ
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1189-94. PubMed ID: 3011976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical infections in mice resulting from the modulation of a lethal dose of Semliki Forest virus with defective interfering viruses: neurochemical abnormalities in the central nervous system.
    Barrett AD; Cross AJ; Crow TJ; Johnson JA; Guest AR; Dimmock NJ
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1727-32. PubMed ID: 2426395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in homotypic and heterotypic interference by defective interfering viruses derived from different strains of Semliki Forest virus and from Sindbis virus.
    Barrett AD; Dimmock NJ
    J Gen Virol; 1984 Jun; 65 ( Pt 6)():1119-22. PubMed ID: 6726189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus.
    Barrett AD; Dimmock NJ
    J Gen Virol; 1984 Oct; 65 ( Pt 10)():1827-31. PubMed ID: 6092526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report.
    Barrett AD; Dimmock NJ
    Arch Virol; 1984; 81(1-2):185-8. PubMed ID: 6331348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.
    Thomson M; White CL; Dimmock NJ
    Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
    Dimmock NJ; Kennedy SI
    J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge.
    Grosfeld H; Velan B; Leitner M; Cohen S; Lustig S; Lachmi BE; Shafferman A
    J Virol; 1989 Aug; 63(8):3416-22. PubMed ID: 2473217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective interfering Semliki Forest virus populations are biologically and physically heterogeneous.
    Barrett AD; Crouch CF; Dimmock NJ
    J Gen Virol; 1984 Aug; 65 ( Pt 8)():1273-83. PubMed ID: 6747604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
    Boere WA; Kraaijeveld CA; Snippe H
    Antiviral Res; 1985; Suppl 1():149-53. PubMed ID: 2417548
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
    Balcarova J; Helenius A; Simons K
    J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
    Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNS pathogenesis following a dual viral infection with Semliki Forest (alphavirus) and Langat (flavivirus).
    Amor S; Webb HE
    Br J Exp Pathol; 1988 Apr; 69(2):197-208. PubMed ID: 2837265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.
    Kraaijeveld CA; Oosterlaken TA; Snijders A; Benaissa-Trouw BJ; Ekstijn GL; Snippe H
    Antiviral Res; 1992 Oct; 19(4):275-84. PubMed ID: 1281391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice.
    Oosterlaken TA; Harmsen M; Jhagjhoor-Singh SS; Ekstijn GL; Kraaijeveld CA; Snippe H
    J Virol; 1991 Jan; 65(1):98-102. PubMed ID: 1845911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis.
    Boere WA; Benaissa-Trouw BJ; Harmsen M; Kraaijeveld CA; Snippe H
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1405-8. PubMed ID: 6854274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus.
    Kraaijeveld CA; Benaissa-Trouw BJ; Harmsen M; Snippe H
    Arch Virol; 1986; 91(1-2):83-92. PubMed ID: 3489451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.